{"name":"CardioVascular BioTherapeutics, Inc.","slug":"cardiovascular-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPUWhqLUdTNkt5RTFkZjItRDd6RnJrdlpjdDIxWS1GcWhHTUhqQVpHc1dLTVlzdlFEdUhZRXhSVTVXZUp1VkZibTEwbW1GbHdGRDZNX0xyQUxpTG9lSmxYNFdTakN4YW5Lb0w3VFlXb29oY2FyN3MxVXBYS0tQTE4xcXEzTks?oc=5","date":"2026-03-13","type":"trial","source":"Market Data Forecast","summary":"Angina Pectoris Drugs Market Size, Share & Growth, 2034 - Market Data Forecast","headline":"Angina Pectoris Drugs Market Size, Share & Growth, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQX3Nkc0FTNk5HNHNFUlYtYktjeEpqaGdrdFBpR2hDckx2RlQySWJBXzk3bGRCS2dQejFBbGtBNFdGaVZPS20xQy00MFF2MzktUkRQaDBUNlY2ZmxjNm9QbDMxaXAwRVg4Y1NVbWhxMmxCUEJhWC1WOFVMdTFNQzJZRmlQR3FUTzZ1WFJGektlNFdoQnRmOTZCbGh2Y2tBMFFaa1I0MzdWOHNKc0M3RW1uMGR0WTEzZWQ2TUxVVkJKTWM?oc=5","date":"2026-02-27","type":"deal","source":"Fierce Biotech","summary":"Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates - Fierce Biotech","headline":"Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPaVY5d05KOEZTRVpiZWMwNE1RbDNpQ2otdXZJZmdTWEM5Mm8wZUJtenJJWWZUaUFfTXFsVDVGclhSUktXTTh5My02b19ZVW9lZWhqUU54WVNLNWZNQ1R3bWhkSWxGRGUwUHNLYTdYSDctZndPTzVrMHl6bGdJOFllYTBENVRBZ0Z2R19tWQ?oc=5","date":"2025-10-13","type":"trial","source":"Yahoo Finance","summary":"Cardiovascular Drugs Market Size to Reach US$ 247.8 Billion by 2033, Driven by Rising Cardiovascular Disease Cases and Lifestyle Changes | According to DataM Intelligence - Yahoo Finance","headline":"Cardiovascular Drugs Market Size to Reach US$ 247.8 Billion by 2033, Driven by Rising Cardiovascular Disease Cases and L","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOaHVXZjVoak1BMnZldzNLVDVTckN1ZW1MV0JPMWhUSmRTUVpzSFg0VDF5bS1wY2lDWlZIZ3BYY1c3ajVHdW5YQWFNLXNfbklVWnQ4ZGlObmxkdHNNVTNuUGVlSG1GajB6VlRjSlk2NENDVExId2I0cW1uVHB2SWNBbXRhVXQtbEh3QlF4alRqOVdpVjFmNUd6X2t5SThLVi1kcGZGZkYtR25yTXh1dm53ZnNJcFhHbzRYTEwwMUo3T3F5S25PWmszakVXY0dpTExjdVlrWkxLUk9heC1lR1VqVEN3djZNSGdLU2dfLWJkdHN5TGta?oc=5","date":"2025-09-16","type":"pipeline","source":"GlobeNewswire","summary":"Imbria Pharmaceuticals Strengthens Leadership with New Board and Key Clinical Appointments - GlobeNewswire","headline":"Imbria Pharmaceuticals Strengthens Leadership with New Board and Key Clinical Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNNXM3UUwyUjhJZGJNd2tuUlNXb05tT01DR0M3VGo0aTlTVWxJSm9rSWFTcTlhb1NvNDJ2Vm94OEo5MEo3cnJmbGg1NUp1MWlpX3pSZ0cyX0w4dGRod21zY0t0WFlQdHdpYmJpaTZjNW9KV0t0T1hONVp1YnRZR0FManktakNuOHNmMV9wMEtocVRkeWVBSkJ3eGpXc1dMempjR3JINkJOSk5kV0J4di1rR2NJMzVocGhiM1NVT3dsVUZwemVzUThR?oc=5","date":"2025-08-20","type":"pipeline","source":"Dallas Innovates","summary":"Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles - Dallas Innovates","headline":"Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPWG5nR1hNQTYzVmo1bzZDUzM0LWRqeUZDeTUzVUNGdFE1cmxHOU81bHluNVZ1QTJmcnprSmFmV1ZVU091b3hLQnlQS2xjVm15YU1mamJpbDNwNlpfckpGN0dISTRGQVVfQzhpMTFEUXl2Q0xOSU5tOXREODZ2ZHprWHdFRFhRQ244Z2JhenpQZ05OUVFuMnE0ejNCRTBWengtX1VsaWk1TDFVcUhSdDVJZ2lXYk1nZi1OS3Vjb3diZw?oc=5","date":"2025-06-17","type":"deal","source":"Eli Lilly","summary":"Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly","headline":"Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNbktvdG1tNkhGeVIxU3lpVjZyRjY0MlJpSjdYaHF2aUQ4b1BDVkNIbDhlcWhRWEJjRmsyM3F2clRsby1UVHNId2dpdm5nNUNuZXh0VDE4SmRjM1czOWdmUVpXOC1hRlBBcTZiVURCeWpKR08tWFVTRkNGeVEtY1FFaUhYZUNYc0RvclRHUU85ZnlONzZzVzY5M0FSNDY1T2J4NGRwVlJKNi1jd0Q3MUxEZ3ZYZk4yZFh4WDkwUVF1WkE2VTVoNmc?oc=5","date":"2025-06-04","type":"deal","source":"BioSpace","summary":"Cadrenal Therapeutics to Engage Potential Partners at BIO International Convention 2025 - BioSpace","headline":"Cadrenal Therapeutics to Engage Potential Partners at BIO International Convention 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOGpEU2Z3TVhzcEQ1aGRDNVlvVjg3VUxxeERPYVdVYzBqRkx1QTdFZWlXM1R5Yl8yX0FVZmplQUJqbGNXTUk4bGdSNWdIZTliN2NWS0dFSGZtcVMzaHhvaGtfZlRRYWk4bWFJdGJCMUF5ZjV3aUptZklVbjI4VGF6NklVRFpyY0YxcTZvTHRHOVlZOU1tMW12dVZtak9URTJVWVBXc3pSeWpuQU9VS3BrVHpJR2ZrbkF4a3hOTmF6TF94QQ?oc=5","date":"2025-05-01","type":"pipeline","source":"European Pharmaceutical Review","summary":"New $1.7b Novartis acquisition to advance novel microRNA inhibitor | News - European Pharmaceutical Review","headline":"New $1.7b Novartis acquisition to advance novel microRNA inhibitor | News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxPYUM1RmhTUERKLURCRnF2X05qbS10bUFpLUpQVEJUdzU1X08xdGdUTzV2aElERWtnTjlvY1pqU3JMU0tkQUd5UkZfdzdmVVJnS0t4ajVvZlFlWDdxVUh4VVRwYkE3bDVBTk5LT18yLUpsNjYxV3JyX1JoUWt1X0VTckFsc3QwRS14VlQxQTR5UGZoNEJkblNTWDRKdlpRS1BMX1FqcDlkNFZ6bEI4Y0dkMWtXQ3d5cjdDV2pQZmMzdkJrUW0yUG9uRFV4S2VlTGRfVFNlV2RXb1JqaFF3SGRfa3F4NWI5cDhVLXFJdVJ6cGxhbTlVLU5sQmpiazBEYzJQUFNEQjZpX2pibWpvSFA2RjlpUQ?oc=5","date":"2025-03-13","type":"pipeline","source":"businesswire.com","summary":"Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin - businesswire.com","headline":"Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1nekFvOFVKVkN2VjRQVk9RcTlkbVVwaFBYenozOU85TmRyU09aUzZYN29wZTdUSmowbFg0SUllVE1uX3pIa1NBM2JuX0hzemhkSExPOW9xdXRKejI5aTc2dUs2eUpNaGhmRXc?oc=5","date":"2024-10-10","type":"trial","source":"ahajournals.org","summary":"Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases - ahajournals.org","headline":"Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBRNXI3dGFXbHFBS2hLcDdRVl9PRHRkNTRFODRyM2c2NXd2YnNBWWxSY043Mm5Fa1V0R0tMRnZPbVN4N2NMdjFfejBfOXVGRWI1bjh4QlUtVjdxTXVnZFY2Qg?oc=5","date":"2024-04-06","type":"pipeline","source":"JACC Journals","summary":"Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI - JACC Journals","headline":"Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQX1VuWmh5WWpPdWtKbXdKTVN0U2dlSXpDSmpRQ1pWR0l4SlRjN0dKamhCd0w5Zmk5V0pXSE4wOU8xRXNlQnY0cUpnalB0ejdfTE4tSmlPelVEQTdnZGFaemlWYXdZZmJzUndieUFGTmdVT3BhYWdMaVV2RU1iQ0tkUDRyb01hMWZqcDNKa0EzLXd6LVhDeDNlR2FlUThQVTc4TWFKdU1OSU1GUGpfZjBCRmZwMmhYMmJHMl9lMnJOdVpwWEZIaUFQT3RTZHJBSmtRTW5SRTlXa24yejlRQlozcklNWV9zS1hQQmRBZDJRdVRzZTdZVGpVMnZQaFZ6M0pDc1NDOHIycTQ5QQ?oc=5","date":"2023-09-26","type":"pipeline","source":"PR Newswire","summary":"Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight - PR Newswire","headline":"Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsi","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}